Zymeworks Inc.
Zymeworks Inc. (ZYME) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ZYME · as of Jun 9, 2026
Key Statistics
Explore Zymeworks Inc. Data
zyme stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 90.0%
The ZYME analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $41.75, representing +74.47% upside from the current price of $23.93.
Competitors & Peers
zyme competitorsZYME
ARDX
BCRX
IMNM
MAZE
NTLAStock Performance
Full HistoryAbout Zymeworks Inc.
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline f…
what is zymeworks inc. · zyme stock overview · zymeworks inc. company profile · who is zymeworks inc. ceo · zyme NASDAQ · zymeworks inc. headquarters · zymeworks inc. business segments
About Stock Overview & Key Data
Zymeworks Inc. (ZYME) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 28, 2017. As of the latest trading session, ZYME stock price is $23.93, with a market capitalization of $1.8B. The stock has returned +90.92% over the past 12 months and -9.72% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Zymeworks Inc. stock is Buy, with an average 12-month price target of $41.75. In fiscal year 2025, Zymeworks Inc. reported revenue of $106.0M and net income of -$81.1M. For detailed data — including Zymeworks Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Zymeworks Inc. (ZYME) stock price is $23.93. The stock is traded on NASDAQ under the ticker symbol ZYME. The 52-week range is $11.51 – $29.75.